~~<i id='BF8430CA4A'><strike id='BF8430CA4A'><tt id='BF8430CA4A'><pre id='BF8430CA4A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：knowledge 2025-08-12 08:28:13 - browse：265

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： In Memoriam: Notable people who died in 2023

hotspot

entertainment

hotspot

focus

AdobeAswearablehealthdevicesgrowmorepopularintheU.S.,there’sagrowingopportunitytotrackthebroaderadul

WSS

Medical experts are missing from AI regulatory conversations

Stanford updates investigation of president’s past research

Trump got a 'target letter.' What is one and what does it mean?

Why the Crimean Bridge is key to Russia's war in Ukraine

Resistance to cancer drugs: A new genetic explanation

State Dept. review finds Biden bears some blame for Afghanistan failures

explore

hotspot

hotspot

Jerome Adams on the need for new antivirals for Covid

States increasingly look to regulate hospital facility fees

Drug repurposing or repositioning? The language matters

Stanford president to resign after investigation of research

Trump demands the U.S. pay no more for drugs than other countries … again

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Wildfire smoke exposes gaps in outdoor worker protections

Hepatitis C has a cure — but many Americans still lack access to it

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

Walensky prepares to leave CDC — and Congress — behind

Dobbs anniversary: the lost opportunity of abortion as health care

Jerome Adams on the need for new antivirals for Covid

New warning issued for rebooking air travel after delays, cancellations

What does generative AI mean for health care? We asked experts

hotspot

hotspot

hotspot

focus